Review



leukaemia inhibitory factor  (Cusabio)


Bioz Verified Symbol Cusabio is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cusabio leukaemia inhibitory factor
    Leukaemia Inhibitory Factor, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+lif+elisa+kit/Rat+leukemia+inhibitory+factor%2CLIF+ELISA+Kit/10__1016_slash_j__rbmo__2024__104486-132-35-40
    Average 93 stars, based on 4 article reviews
    leukaemia inhibitory factor - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis.
    Article Snippet: Human LIF ELISA kit, human LIF IgG2B monoclonal antibody from mouse, and biotinylated human LIF IgG polyclonal antibody from goat were from R&D System (Minneapolis, MN). .. Rat LIF ELISA kit was from Cusabio (Wuhan, China). .. AlphaScreen protein A acceptor beads and AlphaScreen streptavidin-coated donor beads were from PerkinElmer (Waltham, MA).

    Article Title: 3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium.
    Article Snippet: Common events in the clinic, such as uterine curettage or inflammation, may lead to irreversible endometrial damage, often resulting in infertility in women of childbearing age.. Currently, tissue engineering has the potential to achieve tissue manipulation, regeneration, and growth, but personalization and precision remain challenges.. The application of “3D cell printing” is more in line with the clinical requirements of tissue repair.



    Similar Products

    93
    Cusabio leukaemia inhibitory factor
    Leukaemia Inhibitory Factor, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+lif+elisa+kit/Rat+leukemia+inhibitory+factor%2CLIF+ELISA+Kit/10__1016_slash_j__rbmo__2024__104486-132-35-40
    Average 93 stars, based on 1 article reviews
    leukaemia inhibitory factor - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    ELK Biotechnology rat-specific lif elisa kits elk5072
    <t>LIF</t> expression in renal biopsies and urine from CKD patients. (a) The expression of LIF along with the decline of eGFR (n = 39). (b) The association between the log2 of LIF expression and eGFR (n = 39). (c) Differential expression of IL6 family cytokines between subjects with (n = 33) and without (n = 6) TIF. (d) The expression of LIF in different stages of Oxford-T grades of IgAN (n = 39). (e) Differential expression of IL6 family cytokines between CKD (n = 28) and healthy subjects (n = 9) from the ERCB Nephrotic Syndrome Data set. (f) The association between the log2 of LIF expression and eGFR in subjects (n = 33) from the ERCB Nephrotic Syndrome Data set. (g) Western blot analysis of LIF protein in 24 h-urine. (h) The amount of LIF protein in 24 h-urine was increased along with the stage of Oxford-T grades of IgAN (n = 50) and healthy controls (n = 8). The amount of LIF protein in 24 h-urine was measure by <t>ELISA.</t> (i) The amount of LIF protein in 24 h-urine negatively correlated with eGFR of IgAN patients (n = 50). (j–l) The level of uLIF at baseline predicts the risk of CKD progression to ESRD. Tertiles of uLIF-7 levels had a graded relationship with the risk of CKD progression to ESRD in total cohort (j), in subgroups of patients with eGFR <60 ml/min/1.73 m 2 (k) and patients with proteinuria >1.0 g/d (l). Data in (a), (d) and (h) were represented as median ± interquartile range (IQR) and P values were determined by one-way ANOVA (Least-Significant Difference test). The Spearman correlation analysis was used in (b), (f) and (i). The R package limma (3.46.0) was used in (c) and (e) for gene differential expression analysis between two groups. Data in (j), (k) and (l) were generated using the Kaplan–Meier method and compared using the log-rank test.
    Rat Specific Lif Elisa Kits Elk5072, supplied by ELK Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+lif+elisa+kit/rat+specific+lif+elisa+kits+elk5072/pmc09646860-265-20-25
    Average 90 stars, based on 1 article reviews
    rat-specific lif elisa kits elk5072 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Cusabio rat mid oc elisa kit
    <t>LIF</t> expression in renal biopsies and urine from CKD patients. (a) The expression of LIF along with the decline of eGFR (n = 39). (b) The association between the log2 of LIF expression and eGFR (n = 39). (c) Differential expression of IL6 family cytokines between subjects with (n = 33) and without (n = 6) TIF. (d) The expression of LIF in different stages of Oxford-T grades of IgAN (n = 39). (e) Differential expression of IL6 family cytokines between CKD (n = 28) and healthy subjects (n = 9) from the ERCB Nephrotic Syndrome Data set. (f) The association between the log2 of LIF expression and eGFR in subjects (n = 33) from the ERCB Nephrotic Syndrome Data set. (g) Western blot analysis of LIF protein in 24 h-urine. (h) The amount of LIF protein in 24 h-urine was increased along with the stage of Oxford-T grades of IgAN (n = 50) and healthy controls (n = 8). The amount of LIF protein in 24 h-urine was measure by <t>ELISA.</t> (i) The amount of LIF protein in 24 h-urine negatively correlated with eGFR of IgAN patients (n = 50). (j–l) The level of uLIF at baseline predicts the risk of CKD progression to ESRD. Tertiles of uLIF-7 levels had a graded relationship with the risk of CKD progression to ESRD in total cohort (j), in subgroups of patients with eGFR <60 ml/min/1.73 m 2 (k) and patients with proteinuria >1.0 g/d (l). Data in (a), (d) and (h) were represented as median ± interquartile range (IQR) and P values were determined by one-way ANOVA (Least-Significant Difference test). The Spearman correlation analysis was used in (b), (f) and (i). The R package limma (3.46.0) was used in (c) and (e) for gene differential expression analysis between two groups. Data in (j), (k) and (l) were generated using the Kaplan–Meier method and compared using the log-rank test.
    Rat Mid Oc Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+lif+elisa+kit/Rat+leukemia+inhibitory+factor%2CLIF+ELISA+Kit/pmc08918239-75-5-19
    Average 93 stars, based on 1 article reviews
    rat mid oc elisa kit - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Abbexa Ltd rat lif elisa kit
    <t>LIF</t> expression in renal biopsies and urine from CKD patients. (a) The expression of LIF along with the decline of eGFR (n = 39). (b) The association between the log2 of LIF expression and eGFR (n = 39). (c) Differential expression of IL6 family cytokines between subjects with (n = 33) and without (n = 6) TIF. (d) The expression of LIF in different stages of Oxford-T grades of IgAN (n = 39). (e) Differential expression of IL6 family cytokines between CKD (n = 28) and healthy subjects (n = 9) from the ERCB Nephrotic Syndrome Data set. (f) The association between the log2 of LIF expression and eGFR in subjects (n = 33) from the ERCB Nephrotic Syndrome Data set. (g) Western blot analysis of LIF protein in 24 h-urine. (h) The amount of LIF protein in 24 h-urine was increased along with the stage of Oxford-T grades of IgAN (n = 50) and healthy controls (n = 8). The amount of LIF protein in 24 h-urine was measure by <t>ELISA.</t> (i) The amount of LIF protein in 24 h-urine negatively correlated with eGFR of IgAN patients (n = 50). (j–l) The level of uLIF at baseline predicts the risk of CKD progression to ESRD. Tertiles of uLIF-7 levels had a graded relationship with the risk of CKD progression to ESRD in total cohort (j), in subgroups of patients with eGFR <60 ml/min/1.73 m 2 (k) and patients with proteinuria >1.0 g/d (l). Data in (a), (d) and (h) were represented as median ± interquartile range (IQR) and P values were determined by one-way ANOVA (Least-Significant Difference test). The Spearman correlation analysis was used in (b), (f) and (i). The R package limma (3.46.0) was used in (c) and (e) for gene differential expression analysis between two groups. Data in (j), (k) and (l) were generated using the Kaplan–Meier method and compared using the log-rank test.
    Rat Lif Elisa Kit, supplied by Abbexa Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+lif+elisa+kit/rat+myeloperoxidase+elisa+kit/pm33974468-40-7-11
    Average 90 stars, based on 1 article reviews
    rat lif elisa kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Cusabio rat lif elisa kit
    <t>LIF</t> expression in renal biopsies and urine from CKD patients. (a) The expression of LIF along with the decline of eGFR (n = 39). (b) The association between the log2 of LIF expression and eGFR (n = 39). (c) Differential expression of IL6 family cytokines between subjects with (n = 33) and without (n = 6) TIF. (d) The expression of LIF in different stages of Oxford-T grades of IgAN (n = 39). (e) Differential expression of IL6 family cytokines between CKD (n = 28) and healthy subjects (n = 9) from the ERCB Nephrotic Syndrome Data set. (f) The association between the log2 of LIF expression and eGFR in subjects (n = 33) from the ERCB Nephrotic Syndrome Data set. (g) Western blot analysis of LIF protein in 24 h-urine. (h) The amount of LIF protein in 24 h-urine was increased along with the stage of Oxford-T grades of IgAN (n = 50) and healthy controls (n = 8). The amount of LIF protein in 24 h-urine was measure by <t>ELISA.</t> (i) The amount of LIF protein in 24 h-urine negatively correlated with eGFR of IgAN patients (n = 50). (j–l) The level of uLIF at baseline predicts the risk of CKD progression to ESRD. Tertiles of uLIF-7 levels had a graded relationship with the risk of CKD progression to ESRD in total cohort (j), in subgroups of patients with eGFR <60 ml/min/1.73 m 2 (k) and patients with proteinuria >1.0 g/d (l). Data in (a), (d) and (h) were represented as median ± interquartile range (IQR) and P values were determined by one-way ANOVA (Least-Significant Difference test). The Spearman correlation analysis was used in (b), (f) and (i). The R package limma (3.46.0) was used in (c) and (e) for gene differential expression analysis between two groups. Data in (j), (k) and (l) were generated using the Kaplan–Meier method and compared using the log-rank test.
    Rat Lif Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+lif+elisa+kit/Rat+leukemia+inhibitory+factor%2CLIF+ELISA+Kit/pm32911103-150-7-11
    Average 93 stars, based on 1 article reviews
    rat lif elisa kit - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Cusabio rat gaba elisa kit
    <t>LIF</t> expression in renal biopsies and urine from CKD patients. (a) The expression of LIF along with the decline of eGFR (n = 39). (b) The association between the log2 of LIF expression and eGFR (n = 39). (c) Differential expression of IL6 family cytokines between subjects with (n = 33) and without (n = 6) TIF. (d) The expression of LIF in different stages of Oxford-T grades of IgAN (n = 39). (e) Differential expression of IL6 family cytokines between CKD (n = 28) and healthy subjects (n = 9) from the ERCB Nephrotic Syndrome Data set. (f) The association between the log2 of LIF expression and eGFR in subjects (n = 33) from the ERCB Nephrotic Syndrome Data set. (g) Western blot analysis of LIF protein in 24 h-urine. (h) The amount of LIF protein in 24 h-urine was increased along with the stage of Oxford-T grades of IgAN (n = 50) and healthy controls (n = 8). The amount of LIF protein in 24 h-urine was measure by <t>ELISA.</t> (i) The amount of LIF protein in 24 h-urine negatively correlated with eGFR of IgAN patients (n = 50). (j–l) The level of uLIF at baseline predicts the risk of CKD progression to ESRD. Tertiles of uLIF-7 levels had a graded relationship with the risk of CKD progression to ESRD in total cohort (j), in subgroups of patients with eGFR <60 ml/min/1.73 m 2 (k) and patients with proteinuria >1.0 g/d (l). Data in (a), (d) and (h) were represented as median ± interquartile range (IQR) and P values were determined by one-way ANOVA (Least-Significant Difference test). The Spearman correlation analysis was used in (b), (f) and (i). The R package limma (3.46.0) was used in (c) and (e) for gene differential expression analysis between two groups. Data in (j), (k) and (l) were generated using the Kaplan–Meier method and compared using the log-rank test.
    Rat Gaba Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rat+lif+elisa+kit/Rat+leukemia+inhibitory+factor%2CLIF+ELISA+Kit/pm27606701-136-10-14
    Average 93 stars, based on 1 article reviews
    rat gaba elisa kit - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    LIF expression in renal biopsies and urine from CKD patients. (a) The expression of LIF along with the decline of eGFR (n = 39). (b) The association between the log2 of LIF expression and eGFR (n = 39). (c) Differential expression of IL6 family cytokines between subjects with (n = 33) and without (n = 6) TIF. (d) The expression of LIF in different stages of Oxford-T grades of IgAN (n = 39). (e) Differential expression of IL6 family cytokines between CKD (n = 28) and healthy subjects (n = 9) from the ERCB Nephrotic Syndrome Data set. (f) The association between the log2 of LIF expression and eGFR in subjects (n = 33) from the ERCB Nephrotic Syndrome Data set. (g) Western blot analysis of LIF protein in 24 h-urine. (h) The amount of LIF protein in 24 h-urine was increased along with the stage of Oxford-T grades of IgAN (n = 50) and healthy controls (n = 8). The amount of LIF protein in 24 h-urine was measure by ELISA. (i) The amount of LIF protein in 24 h-urine negatively correlated with eGFR of IgAN patients (n = 50). (j–l) The level of uLIF at baseline predicts the risk of CKD progression to ESRD. Tertiles of uLIF-7 levels had a graded relationship with the risk of CKD progression to ESRD in total cohort (j), in subgroups of patients with eGFR <60 ml/min/1.73 m 2 (k) and patients with proteinuria >1.0 g/d (l). Data in (a), (d) and (h) were represented as median ± interquartile range (IQR) and P values were determined by one-way ANOVA (Least-Significant Difference test). The Spearman correlation analysis was used in (b), (f) and (i). The R package limma (3.46.0) was used in (c) and (e) for gene differential expression analysis between two groups. Data in (j), (k) and (l) were generated using the Kaplan–Meier method and compared using the log-rank test.

    Journal: eBioMedicine

    Article Title: Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis

    doi: 10.1016/j.ebiom.2022.104312

    Figure Lengend Snippet: LIF expression in renal biopsies and urine from CKD patients. (a) The expression of LIF along with the decline of eGFR (n = 39). (b) The association between the log2 of LIF expression and eGFR (n = 39). (c) Differential expression of IL6 family cytokines between subjects with (n = 33) and without (n = 6) TIF. (d) The expression of LIF in different stages of Oxford-T grades of IgAN (n = 39). (e) Differential expression of IL6 family cytokines between CKD (n = 28) and healthy subjects (n = 9) from the ERCB Nephrotic Syndrome Data set. (f) The association between the log2 of LIF expression and eGFR in subjects (n = 33) from the ERCB Nephrotic Syndrome Data set. (g) Western blot analysis of LIF protein in 24 h-urine. (h) The amount of LIF protein in 24 h-urine was increased along with the stage of Oxford-T grades of IgAN (n = 50) and healthy controls (n = 8). The amount of LIF protein in 24 h-urine was measure by ELISA. (i) The amount of LIF protein in 24 h-urine negatively correlated with eGFR of IgAN patients (n = 50). (j–l) The level of uLIF at baseline predicts the risk of CKD progression to ESRD. Tertiles of uLIF-7 levels had a graded relationship with the risk of CKD progression to ESRD in total cohort (j), in subgroups of patients with eGFR <60 ml/min/1.73 m 2 (k) and patients with proteinuria >1.0 g/d (l). Data in (a), (d) and (h) were represented as median ± interquartile range (IQR) and P values were determined by one-way ANOVA (Least-Significant Difference test). The Spearman correlation analysis was used in (b), (f) and (i). The R package limma (3.46.0) was used in (c) and (e) for gene differential expression analysis between two groups. Data in (j), (k) and (l) were generated using the Kaplan–Meier method and compared using the log-rank test.

    Article Snippet: The concentration of LIF in the culture medium of normal rat kidney interstitial fibroblast cell lines (NRK49F) was determined using rat-specific LIF ELISA kits (ELK5072, ELK Biotechnology, Wuhan, China).

    Techniques: Expressing, Quantitative Proteomics, Western Blot, Enzyme-linked Immunosorbent Assay, Generated

    Upstream regulators of LIF expression. (a–e) LIF upregulated the expression of itself in NRK49F cells through ERK-EGR1 axis. NRK49F cells were treated with LIF for 24 h. (a) Real-time PCR showed that LIF upregulated itself in NRK49F cells. Relative Lif mRNA levels were shown as fold induction over controls after normalization with gapdh, respectively. ∗ P < 0.01 versus controls (n = 3). (b and c) Western blot analyses (b) and quantitative data (c) showed that LIF induced the expression of itself and EGR1 in a dose-dependent manner. # P < 0.05, ∗ P < 0.01 versus controls (n = 4). (d and e) Western blot analyses (d) and quantitative data (e) showed that knocking down EGR1 diminished LIF-induced LIF production. # P < 0.05, ∗ P < 0.01 versus NC+LIF (n = 4). (f) Upstream regulators of Lif expression. NRK49F cells were treated with OSM (20 ng/ml) and IL11 (10 ng/ml). (g) Upstream regulators of Lif expression. NRK49F cells were treated with TGF-β1 (8 ng/ml), TNF-α (8 ng/ml) and Ang II (10 nM/ml) for 24 h. Real-time PCR measured the mRNA level of Lif . Relative Lif mRNA levels were showed as fold induction over controls after normalization with gapdh, respectively. ∗ P < 0.01 versus controls (n = 4). (h) The mRNA level of Lif were induced by TGF-β1 induced LIF expression in a dose-dependent manner in NRK49F cells. ∗ P < 0.01 versus controls (n = 4). (i and j) Western blotting Representative Western blot (i) and quantitative data (j) showed that the protein level of LIF were induced by TGF-β1 in a dose-dependent manner in NRK49F cells. # P < 0.05, ∗ P < 0.01 versus controls (n = 4). (k) NRK49F cells were treated with TGF-β1 (8 ng/ml) for 24 h, and the LIF concentration in the culture medium was determined by ELISA. ∗ P < 0.01 versus controls (n = 4). Data were expressed as means ± SD. Student's t-test in (f), (g) and (k) or one-way ANOVAs (Least-Significant Difference test or Dunnett's T3 test) in (a), (c), (e), (h) and (j) was used for determining the P values while comparing between each pair of groups, respectively.

    Journal: eBioMedicine

    Article Title: Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis

    doi: 10.1016/j.ebiom.2022.104312

    Figure Lengend Snippet: Upstream regulators of LIF expression. (a–e) LIF upregulated the expression of itself in NRK49F cells through ERK-EGR1 axis. NRK49F cells were treated with LIF for 24 h. (a) Real-time PCR showed that LIF upregulated itself in NRK49F cells. Relative Lif mRNA levels were shown as fold induction over controls after normalization with gapdh, respectively. ∗ P < 0.01 versus controls (n = 3). (b and c) Western blot analyses (b) and quantitative data (c) showed that LIF induced the expression of itself and EGR1 in a dose-dependent manner. # P < 0.05, ∗ P < 0.01 versus controls (n = 4). (d and e) Western blot analyses (d) and quantitative data (e) showed that knocking down EGR1 diminished LIF-induced LIF production. # P < 0.05, ∗ P < 0.01 versus NC+LIF (n = 4). (f) Upstream regulators of Lif expression. NRK49F cells were treated with OSM (20 ng/ml) and IL11 (10 ng/ml). (g) Upstream regulators of Lif expression. NRK49F cells were treated with TGF-β1 (8 ng/ml), TNF-α (8 ng/ml) and Ang II (10 nM/ml) for 24 h. Real-time PCR measured the mRNA level of Lif . Relative Lif mRNA levels were showed as fold induction over controls after normalization with gapdh, respectively. ∗ P < 0.01 versus controls (n = 4). (h) The mRNA level of Lif were induced by TGF-β1 induced LIF expression in a dose-dependent manner in NRK49F cells. ∗ P < 0.01 versus controls (n = 4). (i and j) Western blotting Representative Western blot (i) and quantitative data (j) showed that the protein level of LIF were induced by TGF-β1 in a dose-dependent manner in NRK49F cells. # P < 0.05, ∗ P < 0.01 versus controls (n = 4). (k) NRK49F cells were treated with TGF-β1 (8 ng/ml) for 24 h, and the LIF concentration in the culture medium was determined by ELISA. ∗ P < 0.01 versus controls (n = 4). Data were expressed as means ± SD. Student's t-test in (f), (g) and (k) or one-way ANOVAs (Least-Significant Difference test or Dunnett's T3 test) in (a), (c), (e), (h) and (j) was used for determining the P values while comparing between each pair of groups, respectively.

    Article Snippet: The concentration of LIF in the culture medium of normal rat kidney interstitial fibroblast cell lines (NRK49F) was determined using rat-specific LIF ELISA kits (ELK5072, ELK Biotechnology, Wuhan, China).

    Techniques: Expressing, Real-time Polymerase Chain Reaction, Western Blot, Concentration Assay, Enzyme-linked Immunosorbent Assay